Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06766578 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER_GOV

Sponsor class

Conditions

Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Interventions

RADIATION: Neoadjuvant Therapy(5×3Gy radiotherapy)
DRUG: Neoadjuvant Therapy(tirelizumab, oxaliplatin, S-1)
PROCEDURE: Surgical treatment
DRUG: Adjuvant therapy(SOX chemotherapy)

Sponsor

Shandong Provincial Hospital